Discover
MOLN
Molecular Partners AG
3.58
1 x 3.91
4 x 4.26
bid
ask
+
0.05
1.42%
3 @ 04:00 PM
3.53 -0.05 (1.40%)
| Ytd | -17.89% | |
| 1y | -5.04% |
3.51
day range
3.58
3.51
52 week range
5.36
| Open | 3.54 | Prev Close | 3.53 | Low | 3.51 | High | 3.58 | Mkt Cap | 137.24M |
| Vol | 1.75K | Avg Vol | 1.53K | EPS | -1.68 | P/E | N/A | Forward P/E | -2.96 |
| Beta | 0.54 | Short Ratio | 4.49 | Inst. Own | 5.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 4.02 | 200-d Avg | 4.17 | 1yr Est | 10.37 |
| Income Statement | |||
| Operating Expenses | 13.59M | ||
| Research and Development Expense | 9.61M | ||
| Selling, General and Administrative Expense | 3.98M | ||
| Operating Income | -13.59M | ||
| Interest Expense | 10.00K | ||
| Net Income | -13.56M | ||
| Net Income Common Stock | -13.56M | ||
| Net Income Common Stock (USD) | -16.77M | ||
| Consolidated Income | -13.56M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -13.55M | ||
| Earning Before Interest & Taxes (USD) | -16.75M | ||
| Weighted Average Shares | 37.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 67.93M | ||
| Cash and Equivalents (USD) | 84.00M | ||
| Trade and Non-Trade Receivables | 1.34M | ||
| Current Assets | 71.43M | ||
| Property, Plant & Equipment Net | 4.27M | ||
| Total Assets | 75.70M | ||
| Debt Current | 1.21M | ||
| Total Debt | 3.04M | ||
| Current Liabilities | 9.82M | ||
| Debt Non-Current | 1.83M | ||
| Total Liabilities | 17.15M | ||
| Accumulated Retained Earnings (Deficit) | -335.18M | ||
| Shareholders Equity | 58.54M | ||
| Shareholders Equity (USD) | 72.39M | ||
| Assets Non-Current | 4.27M | ||
| Total Debt (USD) | 3.76M | ||
| Liabilities Non-Current | 7.33M | ||
| Trade and Non-Trade Payables | 1.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 484.00K | ||
| Net Cash Flow from Financing | -210.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.68M | ||
| Capital Expenditure | -20.00K | ||
| Issuance (Purchase) of Equity Shares | 91.00K | ||
| Issuance (Repayment) of Debt Securities | -301.00K | ||
| Net Cash Flow from Investing | 14.40M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.24M | ||
| Net Cash Flow from Operations | -10.79M | ||
| Share Based Compensation | 907.00K | ||